Epidermal growth factor receptor (EGFR) amplification status of isocitrate dehydrogenase-wildtype (IDHwt) lower-grade gliomas (LGGs; grade II/III) is one of the key molecular markers for diagnosing molecular glioblastoma. Our study shows that infiltrative or mixed pattern, lower ADC, lower 5th percentile of ADC, and higher 95th percentile of nCBF may be useful imaging biomarkers for the EGFR amplification of IDHwt LGGs. Moreover, quantitative imaging biomarkers may add value to qualitative imaging parameters (with AUCs of 0.71 and 0.88, p = 0.020).
This abstract and the presentation materials are available to members only; a login is required.